Prognostic Value of NT-proBNP in Acute Heart Failure
Introduction to NT-proBNP Prognosis
- The European Society of Cardiology recommends that a reduction of >30% in NT-proBNP during hospitalization or early post-discharge predicts better outcomes, while persistently elevated levels indicate poor prognosis 1, 2
- NT-proBNP changes during hospitalization are useful for risk stratification and are independent predictors of death or hospital readmission 1, 2
Patient-Specific Factors Influencing NT-proBNP Levels
- Age is a factor, with NT-proBNP levels increasing with age, and different diagnostic thresholds for patients <50 years (>450 ng/L), 50-75 years (>900 ng/L), and >75 years (>1800 ng/L) 1, 2, 6
- Renal function affects NT-proBNP levels, with renal dysfunction (GFR <60 mL/min/1.73 m²) leading to higher and more prolonged elevations 1, 2, 7
Cardiac Factors Influencing NT-proBNP Levels
- The severity of left ventricular dysfunction is inversely related to left ventricular ejection fraction, with NT-proBNP levels being higher in patients with more severe dysfunction 6, 4
- Ongoing cardiac wall stress can lead to markedly elevated NT-proBNP levels even without clinical signs of fluid overload 7
Prognostic Implications of NT-proBNP Elevation
- An admission NT-proBNP concentration >180 ng/L is strongly predictive of death by 76 days 1, 2
- The value with the best balance of sensitivity and specificity for 1-year mortality is >986 ng/L 1, 2
- For each 500 pg/mL NT-proBNP above baseline, there is an increased mortality risk of 3.8% 3, 4